Tetrafluoropyridazine 1 reacts with a range of oxygen-, nitrogen-, sulfur-and carbon-centred nucleophiles to give, in general, products 2 arising from substitution of fluorine para to ring nitrogen.
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2 New efficient synthetic approaches to polyfunctional pyridazine derivatives and rare heterocyclic systems derived from tetrafluoropyridazine are described in this paper.
While the first identification of a pyridazine ring within a natural product structure was reported relatively recently, 1 pyridazine heterocyclic sub-units have been incorporated into a number of successful pharmaceutical products such as Sulfamethoxypyridazine and Nifurprazine (antibacterial agents) and Minaprine (antidepressant) (Fig. 1) . 2 Consequently, new methodology that allows the rapid synthesis of libraries of novel pyridazine derivatives bearing multiple functionality for incorporation in drug discovery campaigns continues to be an important target for medicinal chemists.
Figure 1 Pharmaceuticals containing pyridazine sub-units
In general, pyridazine systems can be constructed by either a variety of ring-forming processes or reactions of an appropriately functionalised pyridazine substrate. In this paper, we describe the synthesis of a range of polysubstituted, bi-and tri-cyclic ring fused pyridazine systems from tetrafluoropyridazine 1 which allows access to some multiply-substituted pyridazine derivatives and various very rare heterocyclic molecular frameworks by sequential S N Ar methodology suitable for parallel synthesis techniques.
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Results and discussion
A series of reactions of tetrafluoropyridazine 1 with model monodentate oxygen-, nitrogen-, carbonand sulfur-centred nucleophiles were carried out to extend the range of systems available for further functionalisation and are collated in Table 1 . In general, reactions of nucleophiles with tetrafluoropyridazine 1 occurred at 0 o C or room temperature in the presence of the strong, nonnucleophilic organic base di-isopropylethyl amine (DIPEA) and using THF as the reaction medium. 
In all cases, products 2a-k, obtained in high yields, were those derived from substitution of fluorine located at the 4-position as we would expect from observations reported previously. 5, 6 This site is the most activated position towards nucleophilic attack as it is para to the activating ring nitrogen and has two ortho and one meta activating fluorine atoms, following principles for processes involving highly reactive heterocycles. 5, 8 The structures of the products 2a-k followed from 19 Whilst all nitrogen-and oxygen-centred nucleophiles gave high yields of mono-substituted products, in contrast, reaction of one equivalent of thiophenol and tetrafluoropyridazine 1 gave only the 4,5-disubstituted product 2l with no monosubstituted product observed by 19 F NMR analysis of the reaction mixture. This reflects the strong ortho activating effect of the sulfur atom which makes the monosubstituted product more reactive towards nucleophiles than 1 itself. 10 Thus, a higher yield of 2l could be obtained upon reaction of 1 with two equivalents of thiophenol in similar reaction conditions.
In contrast, ethanethiol gave only mono-substituted product 2k consistent with the decreasing electron withdrawing ability of the ethanethio substituent compared to the phenylthio case.
Reaction of 1 with phenylmagnesium bromide gave a mixture of two monosubstituted products 2m and 2n in a 5:1 ratio by 19 F NMR analysis of the crude reaction mixture, arising from substitution of the 4-and 3-positions respectively, from which the major product 2m could be purified by repeated recrystallisation. In this reaction, some competing substitution occurs at the 3-position due to the increased reactivity of the nucleophile which allows substitution at the less activated site ortho to ring nitrogen. In the case of reaction of 1 with methylmagnesium bromide, decomposition occurs, likely due to the highly basic reaction mixture that causes deprotonation of the pyridazyllic protons present in any product formed leading to complex reaction mixtures as observed in similar reactions of highly fluorinated pyridine derivatives. (Table 2 ). All reactions were performed using similar conditions to those described above. 
Reactions of model nucleophiles with trifluoropyridazine derivatives 2a,h,k,m gave products 3a-h arising from substitution at the 5-position, para to ring nitrogen. 4,5-Disubstitution was confirmed by 19 F NMR analysis which showed only resonances occuring at ca. _ 85 ppm for each compound 3a-h, consistent with the presence of fluorine ortho-to ring nitrogen. Reactions were noticeably slower for the trifluorinated pyridazines 2a,k,l,m than 1 as would be expected.
Having established that 1 reacts, in the majority of cases, regioselectively with two equivalents of nucleophile successively to give products 3a-h exclusively from sequential substitution of the 4-and 5-positions, we carried out a series of experiments to prepare ring-fused systems 4 arising from corresponding S N Ar reactions of 1 with difunctional nucleophiles. Initial nucleophilic attack on 1 at the 4-positon, followed by subsequent intramolecular cyclisation by substitution of fluorine attached to the most activated 5-position would be expected to occur. Consequently, reactions of tetrafluoropyridazine 1 with a small range of representative difunctional nitrogen nucleophiles were performed (Table 3) . In all cases, the bi-or tri-cyclic ring fused systems 4a-g derived from reaction at the most activated 4-and cyclic amino-imine and 2-aminopyridine derivatives led to the corresponding tricyclic systems 4c-e respectively in high yields.
Whilst imidazo [4,5-d] Sequential trisubstitution of 1 is also possible when a sufficiently activated difluoropyridazine 3f was further reacted with an appropriate nucleophile. Disubstituted system 3f, was reacted with morpholine upon microwave irradiation at 150 °C for 90 min (Scheme 3) and 19 F NMR spectroscopy of the product mixture showed only a single product 6 which could be isolated in 71% yield by column chromatography and its structure was confirmed by X-ray crystallography ( Figure 2 ). The thiophenoxy group is ortho-activating to some extent and the morpholino group is slightly deactivating, explaining the high regioselectivity of this process. Similarly, all the [5,6]-and [6, 6] -ring fused scaffolds synthesised by the processes outlined in Table 3 possess fluorine atoms attached to the pyridine ring which, in principle, are also susceptible towards nucleophilic displacement. Consequently, we studied reactions of representative polycyclic products Reaction of [6, 6] -fused system 4a with nucleophiles was not successful even after prolonged heating with various reactive nucleophiles, reflecting the deactivating influence of the two amino substituents attached to the pyridazine ring. However, reaction of imidazopyridazine 4b with n-butylamine yielded the disubstituted system 7a, arising from replacement of both remaining ring fluorine atoms while reaction of tricyclic scaffold 4c with morpholine gave 7b regioselectively (Scheme 3) and the structure was confirmed by X-ray crystallography (Fig. 3) .
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Figure 3. Molecular structure of 7b
The regioselectivity of the reaction between 4c and morpholine can be explained by a consideration of the relative stabilities of the Meisenheimer intermediates formed by reaction at either the C-1 or C-4
sites. Attack at C-1 allows delocalisation of the negative charge formed over the pyridazine and imidazopyridazine ring system giving a more stable intermediate whilst attack at C-4 only allows delocalisation over the pyridazine ring (Scheme 5).
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Scheme 5. Regioselectivity of nucleophilic substitution for reaction of 4c
Tricyclic system 4d reacted with nucleophiles under microwave irradiation in acetonitrile (Scheme 4)
to give major products arising from substitution of fluorine at C-1. While small quantities of products arising from substitution of C-4 of the pyridazine ring were observed by 19 F NMR analysis of the reaction mixture, major products 7c,d could be isolated by column chromatography or recrystallisation of the crude product mixture. X-ray crystallography confirmed the structure of the 1-diethylamino derivative 7e (Fig. 4) and NMR data obtained for 7a,b were comparable to those obtained for 7e. In this case, nucleophilic attack at C-1 leads to stabilisation of the Meisenheimer intermediate over the entire aromatic system whilst attack at C-4 only allows charge to be delocalised over the pyridazine ring and, consequently, reactions arising from displacement of fluorine at C-1 are preferred. An alternative method for the synthesis of functionalized pyridazine ring fused polycyclic derivatives is to carry out annelation reactions of monofunctionalised trifluoropyridazines 2 with appropriate difunctional nucleophiles (Table 4) . in good yield. 2-Mercaptophenol gave the fused bicyclic product 9d as the only product as observed by 19F NMR analysis of the crude reaction mixture and crystals that were suitable for analysis by X-ray crystallography allowed the confirmation of the structure (Fig. 5 ). It appears that the initial attack is performed by the sulfur atom giving initial substitution para to ring nitrogen, further activating the intermediate to nucleophilic attack by the oxygen atom at the adjacent site. Reaction of 2k with 2-aminophenol using microwave irradiation at 100 °C for five minutes gave the tricyclic product 9e, confirmed by X-ray crystallography (Fig. 5) , which demonstrated that the product was formed via initial attack by nitrogen followed by cyclisation through oxygen. Similarly, 2-aminobenzenethiol, 2-aminopyridine, 2-amino-3-picoline and ethyl acetoacetate gave the desired polycyclic products 9f-i respectively after reaction with 4-(ethylthio)-3,5,6-trifluoropyridazine 2k under microwave irradiation.
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Conclusions
Tetrafluoropyridazine 1 may be used as a very effective scaffold for the synthesis of a range of 4,5-disubstituted pyridazine systems bearing oxygen, nitrogen, sulfur and carbon functionality. Further substitution of the difluorinated systems gave mixtures of trisubstituted pyridazine systems, processes
which were particularly regioselective in the presence of an ortho-activating sulfur substituent.
Consequently, we have further extended our general strategy for using perfluorinated heteroaromatic scaffolds for analogue synthesis to pyridazine systems.
Novel bi-and tri-cyclic heterocyclic systems have been synthesised by reaction of tetrafluoropyridazine with bifunctional nitrogen centred nucleophiles providing access to tetrahydropyrazino-pyridazine, imidazopyridazine and tetraazafluorene scaffolds. The presence of fluorine atoms attached to sites activated towards nucleophilic attack allows functionalisation of these scaffolds and representative examples of nucleophilic aromatic substitution processes have been established. The developing use of highly fluorinated heteroaromatic derivatives as starting materials for heterocyclic synthesis has been further expanded to ring fused pyridazine systems.
The general strategy outlined in Scheme 1 has allowed the synthesis of a wide range of polyfunctionalised and ring-fused pyridazine derivatives from tetrafluoropyridazine and the synthetic methodology is summarised in Scheme 6, demonstrating the diverse molecular structures that can be accessed very readily after a few simple operations.
Scheme 6. Synthesis of pyridazine based systems from tetrafluoropyridazine
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Experimental General
Reactions were performed under an atmosphere of argon gas using dry solvents. performed on a Thermo-Finnigan LTQ-FT spectrometer. Gas chromatography was carried out on a Thermo TRACE GC. Analytical HPLC was performed on an Analytical Varian LC (5ml/min).
Elemental analyses were obtained using an Exeter Analytical E-440 Elemental Analyser.
X-ray crystallography
The X-ray single crystal data have been collected on a Bruker SMART CCD 1K (compounds 7b and 9e), a Bruker SMART CCD 6000 (compounds 7e, 9d and 9h) and a Rigaku R-AXIS SPIDER IP 
Reactions of Tetrafluoropyridazine 1 with nucleophiles
General procedure
A mixture of tetrafluoropyridazine 1, DIPEA, amine and THF (10 mL) was stirred for the required time under an atmosphere of nitrogen. The mixture was evaporated to dryness in vacuo, partitioned between ethyl acetate (20 mL) and water (20 mL), the phases were separated and the aqueous phase was extracted further by ethyl acetate (3 x 20 mL). The combined organic phases were dried (MgSO 4 ) and evaporated in vacuo. Purification by column chromatography or HPLC on silica gel using cyclohexane and ethyl acetate as eluent gave the pure product.
4-(3,5,6-Trifluoro-pyridazin-4-yl)morpholine 2a
Tetrafluoropyridazine 1 (781 mg, 5.14 mmol), DIPEA (1.35 mL, 7.73 mmol), morpholine (0.45 mL, 5.17 mmol) and THF (10 mL) after stirring at 0 °C for 2 h gave 4- (3,5,6-trifluoro-4-pyridazinyl) 
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
27
A mixture consisting of DIPEA, nucleophile, trifluorophenylpyridazine and THF was heated and stirred as approprite. The mixture was concentrated in vacuo, partitioned between EtOAc (20 mL) and water (20 mL) and the aqueous phase was further extracted with EtOAc (2 x 20 mL). The combined organic phases were concentrated in vacuo and dried (MgSO 4 ). Column chromatography on silica gel gave the difunctional difluoropyridazine product.
4-(3,6-Difluoro-5-phenyl-4-pyridazinyl)morpholine 3a
DIPEA (0.18 mL, 1.03 mmol), morpholine (0.06 mL, 0.68 mmol), 3,4,6-trifluoro-5-phenylpyridazine 2m (143 mg, 0.680 mmol) and THF (10 mL) after stirring at rt for 4 d and column chromatography on silica gel using a 5-25% THF in cyclohexane gradient as eluent gave 4- (3,6-difluoro-5-phenyl-4-pyridazinyl 
4-{3,6-Difluoro-5-[(1-methylethyl)oxy]-4-pyridazinyl}morpholine 3b
Method A: DIPEA (0.20 mL, 1.15 mmol), morpholine (0.07 mL, 0.80 mmol), 3,4,6-trifluoro-5-[(1-methylethyl) oxy]pyridazine 2l (153 mg, 0.80 mmol) and THF (10 mL) after stirring at rt for 4 d and column chromatography on silica gel using a 5-25% THF in cyclohexane gradient as eluent gave 4-{3,6-difluoro-5-[(1-methylethyl) 
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Method B: Lithium isopropoxide (2 M in THF, 0.45 mL, 0.90 mmol), 4-(3,5,6-trifluoro-4- pyridazinyl)morpholine 2a (195 mg, 0.89 mmol) and THF (10 mL) at -78 °C, stirring for 16 h at rt overnight and column chromatography on silica gel using a 2-13% EtOAc in toluene gradient as eluent gave 4-{3,6-difluoro-5-[(1-methylethyl) oxy]-4-pyridazinyl}morpholine 3b (94 mg, 41%) as white crystals; physical and spectroscopic data as above.
4-(5-(Ethylthio)-3,6-difluoropyridazin-4-yl)morpholine 3c
DIPEA (0.27 mL, 1.5 mmol), morpholine (0.09 mL, 1.03 mmol), 4-(ethylthio)-3,5,6-trifluoropyridazine 2k (200 mg, 1.03 mmol) and THF (10 mL) after stirring at rt for 16 h and column chromatography on silica gel using hexane as eluent gave 4-(5-(ethylthio)-3,6-difluoropyridazin-4-yl) 3, oxy]-5-(phenylthio)pyridazine 3e DIPEA (0.22 mL, 1.3 mmol), thiophenol (0.08 mL, 0.75 mmol), 3,4,6-trifluoro-5-[(1-methylethyl) oxy]pyridazine 2l (160 mg, 0.833 mmol) and THF (10 mL) after stirring at 0 °C for 1 h and column chromatography on silica gel using 1-7% THF in cyclohexane gradient as eluent gave 3,6-difluoro-4-[(1-methylethyl) 
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A mixture of tetrafluoropyridazine 1 (0.60 g, 3.96 mmol), benzamidine hydrochloride (0.68 g, 4.35mmol), sodium hydrogen carbonate (1.32 g, 15.8 mmol) and acetonitrile (100 mL) was heated at reflux for 16 h. After this period, the solvent was evaporated and the residue dissolved in ethyl acetate (50 mL). Water (25 mL) was added and the aqueous layer extracted with ethyl acetate (2 × 25 mL).
The combined organic extracts were dried (MgSO 4 ), filtered, evaporated, recrystallised from ethyl acetate and hexane (1:1) to give N- (3,5,6-trifluoropyridazin-4-yl) ,4-difluoro-5,6,7,8-tetrahydro-2,3,4b,9-tetraaza- 
1,4-Difluoro-8-methyl-2,3,4b,9-tetraaza-fluorene 4d
A mixture of tetrafluoropyridazine 1 (0.50 g, 3.28 mmol), 2-amino-3-picoline (0.83 mL, 8.22 mmol) and acetonitrile (1 mL) was subjected to microwave irradiation at 150 o C for 60 min. Water (25 mL) was added and the mixture was extracted with dichloromethane (3 × 25 mL). The combined organic extracts were dried (MgSO 4 ), filtered and evaporated and recrystallised. Column chromatography on silica gel with dichloromethane as eluent gave 1,4-difluoro-8-methyl-2,3,4b,9-tetraaza- 1580, 1433, 1379, 1309, 1281, 1256, 1228, 1165, 1102, 1024, 976 (57), 51 (60), 39 (34).
Tetrafluoropyridazine 1 (0.25 g, 1.64 mmol) was dissolved in dry acetonitrile (20 mL) and 1,2-ethanedithiol (0.15 mL, 1.81 mmol) and sodium hydrogen carbonate (0.28 g, 3.29 mmol) were added.
The mixture was allowed to stir at rt for 2 h before the solvent was evaporated, and the crude reaction mixture partitioned between dichloromethane (20 mL) and water (20 mL) . The aqueous layer was separated before extraction with further portions of dichloromethane (3 × 20 mL) . The combined organic extracts were then dried (MgSO 4 ), filtered and evaporated o provide a crude yellow material which after recrystallisation from acetonitrile gave 5,8-difluoro-2,3-dihydro- [1, 4] 4,7-difluoro-2-methylthiazolo[4,5-d] 
pyridazine 4g
Tetrafluoropyridazine 1 (1.00 g, 6.58 mmol) was mixed with thioacetamide (0.54 g, 7.23 mmol) and sodium hydrogen carbonate (2.21 g, 26 mmol) in acetonitrile (50 mL) under argon. The mixture was stirred at reflux for 16 h, after which the solvent was evaporated, and the crude mixture dissolved in ethyl acetate (25 mL) and water (25 mL). The aqueous layer was separated and acidified with HCl (10%), then extracted with ethyl acetate (2 × 25 mL) and dichloromethane (3 × 25 mL) . The combined organic extracts were dried (MgSO 4 ), filtered and evaporated to yield a crude brown product. Column chromatography on silica gel using ethyl acetate as eluent and recrystallisation from acetonitrile gave 4,7-difluoro-2-methylthiazolo[4,5-d] 4,7-Difluoro-2-phenyl-1H-imidazo [4,5-d] pyridazine 4b (0.10g, 0.43mmol) was dissolved in acetonitrile (1mL) in a 0.5 -2 mL microwave vial, n-butylamine (0.085 ml, 0.86 mmol) was added and the vial sealed. The mixture was heated by microwave irradiation at 150 o C for 20 min before dichloromethane (10 mL) and water (10 mL) were added and the layers separated. The aqueous layer was then washed with further portions of dichloromethane (3 × 10 mL) and the organic extracts combined, dried (MgSO 4 ), filtered and evaporated to yield a crude yellow material. Column chromatography on silica gel using ethyl acetate as eluent gave N4,N7-dibutyl-2-phenyl-1H-imidazo [4,5-d] -1-morpholin-4-yl-5,6,7,8-tetrahydro-2,3,4b,9-tetraaza- -morpholin-4-yl-5,6,7,8-tetrahydro-2,3,4b,9-tetraaza- 3, 4b, 
4-Fluoro
tetraaza-fluorene 7c
A mixture of 1,4-difluoro-8-methyl-2,3,4b,9-tetraaza-fluorene 4d (0.50 g, 2.27 mmol), sodium methoxide (0.31 g, 5.68 mmol) and methanol (3 mL) was heated at 150 o C (microwave) for 20 min.
Water (25 mL) was added and the mixture was extracted with dichloromethane (3 × 25 mL). The combined organic extracts were dried (MgSO 4 ), filtered and evaporated. Column chromatography on silica gel using hexane : ethyl acetate (2:1) as eluent gave 4-fluoro-1-methoxy-8-methyl-2,3,4b,9- (4-fluoro-8-methyl-2,3,4b,9-tetraaza-fluoren-1-yl (4-fluoro-8-methyl-2,3,4b,9-tetraaza-fluoren-1-yl -5,8-dimethyl-4-morpholin-4-yl-5,6,7,8-tetrahydro-pyrazino[2,3-c] pyridazine 9a DIPEA (0.25 mL, 1.5 mmol) and N,N'-dimethyl-ethane-1,2-diamine (0.05 mL, 0.5 mmol) were added to a stirred solution of 4-(3,5,6-trifluoro-pyridazin-4-yl)-morpholine 2a (100 mg, 0.46 mmol) in THF (4 mL), and the mixture was stirred at rt for 5 d. The mixture was concentrated, partitioned between DCM (10 mL) and water (10 mL), the phases were separated and the aqueous phase further extracted with DCM (2 x 10 mL). The organic phases were combined, dried and concentrated. Purification by column chromatography on silica gel using toluene:THF (1:2) as eluent gave 3-fluoro-5,8-dimethyl-4-morpholin-4-yl-5,6,7,8-tetrahydro-pyrazino[2,3-c] pyridazine 9a (103 mg, 84%) as white crystals; mp M A N U S C R I P T DIPEA (1.2 mL, 6.9 mmol) and 2-mercaptophenol (0.23 mL, 2.3 mmol) were added to a stirred solution of 4-(3,5,6-trifluoro-pyridazin-4-yl)-morpholine 2a (504 mg, 2.3 mmol) in THF (4 mL), and the mixture was stirred at rt for 16 h. The mixture was concentrated, partitioned between DCM (10 mL) and water (10 mL), the phases were separated and the aqueous phase further extracted with DCM (2 x 10 mL). The organic phases were combined, dried and concentrated. Purification by column chromatography on silica gel using hexane:ethyl acetate 1-25% as gradient elution, followed by recrystallisation from ethanol gave 3-fluoro-4-morpholin-4-yl-9-oxa-10-thia-1,2-diaza- 
3-Fluoro
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